1266620-74-9: Montelukast Sulfone Impurity

1266620-74-9: Montelukast Sulfone Impurity

Montelukast Sulfone Impurity (CAS No: 1266620-74-9) is an impurity present in montelukast which is used for allergic rhinitis and hives of long duration. It belongs to the quinoline series. It is a curative agent for the medication of bronchial asthma and second-line treatment of allergic rhinitis(AR).

Additional information on CAS 1266620-74-9

Catalogue No.

VL510021
CAS No.

1266620-74-9
Molecular Formula

C₃₅H₃₆ClNO₅S
Molecular Weight

618.18
Parent drug

Montelukast
IUPAC Name

1-[[[1-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfonyl]methyl]cyclopropaneacetic Acid;
Synonyms

1-[[[1-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfonyl]methyl]cyclopropaneacetic Acid;
Smiles

CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S(=O)(=O)CC5(CC5)CC(=O)O)O
References

Emerce, Esra, et al. “Determination of the Impurities in Drug Products Containing Montelukast and in Silico/in Vitro Genotoxicological Assessments of Sulfoxide Impurity.” Toxicology Letters, vol. 238, no. 2, Oct. 2015, pp. 90–99, https://doi.org/10.1016/j.toxlet.2015.07.003. ?Pandey, Lawanya, et al. A REVIEW on TOXICOLOGICAL STUDY of MONTELUKAST. http://www.ijramr.com/sites/default/files/issues-pdf/3731.pdf. Accessed 5 Oct. 2021. ?
Status

In-stock

Other products related to montelukast

[rfq_list]

Login first to add product to RFQ List

Request a quote

1266620-74-9: Montelukast Sulfone Impurity

1266620-74-9: Montelukast Sulfone Impurity
Catalogue No.

VL510021
CAS No.

1266620-74-9
Molecular Formula

C₃₅H₃₆ClNO₅S
Molecular Weight

618.18
Parent drug

Montelukast
IUPAC Name

1-[[[1-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfonyl]methyl]cyclopropaneacetic Acid;
Synonyms

1-[[[1-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfonyl]methyl]cyclopropaneacetic Acid;
Smiles

CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S(=O)(=O)CC5(CC5)CC(=O)O)O
References

Emerce, Esra, et al. “Determination of the Impurities in Drug Products Containing Montelukast and in Silico/in Vitro Genotoxicological Assessments of Sulfoxide Impurity.” Toxicology Letters, vol. 238, no. 2, Oct. 2015, pp. 90–99, https://doi.org/10.1016/j.toxlet.2015.07.003. ?Pandey, Lawanya, et al. A REVIEW on TOXICOLOGICAL STUDY of MONTELUKAST. http://www.ijramr.com/sites/default/files/issues-pdf/3731.pdf. Accessed 5 Oct. 2021. ?
Status

In-stock
ListName

Montelukast Sulfone Impurity
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden